0.17 (-8.99%)
As of Dec 16, 2022
Source:
Scopus Biopharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. our majority-owned subsidiary.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (212) 479-2513 |
| Industry | manufacturing |
| CEO | Joshua R. Lamstein |
| Website | scopusbiopharma.com |